Retail Hiring Surges in April But Consumer Caution Signals Potential Headwinds Pony AI Shares Touch 52Week Low Amid 40 YTD Decline Oversold Conditions Eyed Experian SoFi Technologies Among Financial Services Firms in Market Roundup US Payrolls Surge Beyond Expectations in April Yet Underlying Concerns Emerge Merck Foundation Strengthens Partnership with Ghana First Lady to Expand Healthcare Media Training and Girl Education Indian Youth Cockroach Protest Highlights Growing Frustration Over Unemployment TSM Q1 2026 Earnings EPS Crushes Estimates as AI Demand Fuels Record Profitability IBEX Q1 2026 Earnings EPS Beats Estimates Stock Slips Slightly Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress CVNA Q1 2026 Earnings EPS Beat Drives Stock Higher SNTI Q1 2026 Earnings EPS Beat Surprise as Biotech Advances Pipeline RPT Q1 2026 Earnings Significant EPS Miss as Company Reports Negative Earnings Otis Worldwide OTIS Holds Steady Near Support as Consolidation Continues Valneva VALN Surges 479 as Key Support Holds Resistance in Focus Lotus Technology LOT Slips 074 as Stock Hovers Near Support Key Levels in Focus Azenta Inc AZTA Rallies 159 as Stock Tests Key Technical Levels CrossAmerica Partners LP CAPL Holds Steady A Narrow Trading Range Amid Sector Stability CCI Approves LFPLLed Consortiums Stake Acquisition in Restaurant Brands Asia Valero Energy Q1 2026 Earnings Strong Refining Margins Drive 32 EPS Beat Despite Weaker Stock Reaction Artiva Biotherapeutics Holds Steady with Slight Gain Support at 75 in Focus ARTV SBA Communications Q1 2026 Earnings EPS Miss Weighs on Shares Amid Modest Operational Momentum CEG Q1 2026 Earnings EPS Beats Estimates as Constellation Capitalizes on Nuclear and Clean Energy Demand Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline OLOX Q3 2023 Earnings NarrowerthanExpected Loss Drives 3736 EPS Surprise Customers Bancorp Inc CUBI Q1 2026 Earnings Modest EPS Beat Amid Quiet Quarter JANX Q1 2026 Earnings Narrowed Loss Exceeds Expectations as Pipeline Progress Continues ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains